logo

For the Inventor, By the Inventor

Derio, Spain

Progenika Biopharma S.a.

Calculating rank
USPTO Granted Patents = 16

% Expired Patents = 6.3



Trademarks = 1

Forward Citations = 9

Loading Chart...
Loading Chart...

50 inventors (with patents filed for the assignee):

goldMedal Laureano Simón Buela (7 out of 9 patents)

silverMedal Jorge Ochoa (5 out of 5 patents)

bronzeMedal Monica Lopez (5 out of 5 patents)

4.  Diego Tejedor (5 out of 6 patents)

5.  Antonio Martinez Martinez (5 out of 6 patents)

6.  Antonio Martinez (5 out of 7 patents)

7.  Antonio Martínez Martínez (5 out of 5 patents)

8.  Diego Tejedor Hernández (4 out of 4 patents)

9.  Daniel Nagore Casas (3 out of 4 patents)

10.  Laureano Simon (2 out of 7 patents)

11.  Alberto Monasterio Asteinza (2 out of 2 patents)

12.  Nerea Torres Antúnez (2 out of 2 patents)

13.  Araitz Molano (2 out of 2 patents)

14.  Diego Tejedor Hernandez (2 out of 2 patents)

15.  David Arteta (1 out of 3 patents)


16 patents:

1. 12422444 - Lateral flow immunoassays for the detection of antibodies against biological drugs (2025-09-23),
2. 12215376 - Mitochondrial nucleic acid depletion and detection (2025-02-04),
3. 10851413 - Consensus-based allele detection (2020-12-01),
4. 10830779 - Lateral flow immunoassays for the detection of antibodies against biological drugs (2020-11-10),
5. 10253366 - Discrimination of blood type variants (2019-04-09),
6. 10215762 - Method to optimize the treatment of patients with biological drugs (2019-02-26),
7. 9637788 - Discrimination of blood type variants (2017-05-02),
8. 9359643 - Discrimination of blood type variants (2016-06-07),
9. 9165108 - Probes and methods for determining the presence or absence of genetic segments (2015-10-20),
10. 9109257 - Prognostic method (2015-08-18),
11. 8712696 - Methods of prognosing a rheumatoid arthritis remission phenotype (2014-04-29),
12. 8669049 - Method and device for the detection of mutations in isolated gene sequences of the low-density lipoprotein receptor (LDL-r) which is associated with familial hypercholesterolemia (2014-03-11),
13. 8296073 - Diagnostic method (2012-10-23),
14. 8153363 - Methods and products for in vitro genotyping (2012-04-10),
15. 8124331 - In vitro method to detect bladder transitional cell carcinoma (2012-02-28),
Company Overview
Progenika Biopharma S.A. is a biotechnology company based in Derio, Spain, specializing in the development and manufacturing of innovative solutions for personalized medicine. The company focuses on genetic testing and molecular diagnostics, providing tools that enhance the understanding of genetic predispositions and disease risk. Progenika's expertise spans various domains, including pharmacogenetics and oncology, aiming to improve patient outcomes through tailored therapeutic approaches and advanced diagnostic technologies.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

16 Patents

#1 in Derio

#136 in Spain

#37,887 in the World

Derio, ES
Derio, Spain

Progenika Biopharma S.a.

Forward Citations = 9

50 inventors:

goldMedal Laureano Simón Buela (7 out of 9 patents)

silverMedal Jorge Ochoa (5 out of 5 patents)

bronzeMedal Monica Lopez (5 out of 5 patents)

4.  Diego Tejedor (5 out of 6 patents)

5.  Antonio Martinez Martinez (5 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Progenika Biopharma S.a.. Retrieved from https://idiyas.com/company/progenika-biopharma-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…